AstraZeneca
AZN
AZN
417 hedge funds and large institutions have $7.43B invested in AstraZeneca in 2014 Q2 according to their latest regulatory filings, with 88 funds opening new positions, 75 increasing their positions, 198 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3.26% less ownership
Funds ownership: 19.08% → 15.82% (-3.3%)
6% less capital invested
Capital invested by funds: $7.88B → $7.43B (-$447M)
62% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 198
Holders
417
Holding in Top 10
12
Calls
$954M
Puts
$593M
Top Buyers
| 1 | +$257M | |
| 2 | +$249M | |
| 3 | +$135M | |
| 4 |
YCMGA
York Capital Management Global Advisors
New York
|
+$121M |
| 5 |
OCAM
Owl Creek Asset Management
New York
|
+$111M |
Top Sellers
| 1 | -$639M | |
| 2 | -$498M | |
| 3 | -$284M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$216M |
| 5 |
MAA
Managed Account Advisors
Jersey City,
New Jersey
|
-$195M |